Osmitrol (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Osmitrol drug offered from Baxter Healthcare Corporation. This Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Mannitol
SUBSTANCE NAME: MANNITOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1964-06-08
END MARKETING DATE: 0000-00-00


Osmitrol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOsmitrol from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 5(g/100mL)
START MARKETING DATE: 1964-06-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-0351_57c99c24-bbd8-4b9d-b29c-67e2c2d7a049
PRODUCT NDC: 0338-0351
APPLICATION NUMBER: NDA013684

Other MANNITOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Mannitol
B. Braun Medical Inc.Mannitol
Baxter Healthcare CorporationOsmitrol
Cardinal HealthMannitol
Coson Co., Ltd.GD11 Rx SCM C5
Fresenius Kabi USA, LLCMannitol
General Injectables & Vaccines, IncMannitol
Hospira, Inc.Mannitol